| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/ONC.2010.646 |
| P698 | PubMed publication ID | 21278791 |
| P50 | author | Myriam Alcalay | Q58883437 |
| P2093 | author name string | P G Pelicci | |
| E Colombo | |||
| P2860 | cites work | Nucleolar protein B23 has molecular chaperone activities | Q22009438 |
| Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication | Q24290438 | ||
| Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone | Q24291795 | ||
| Nucleophosmin sets a threshold for p53 response to UV radiation | Q37424634 | ||
| Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance | Q38321981 | ||
| Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity | Q39025073 | ||
| ARF function does not require p53 stabilization or Mdm2 relocalization | Q39675987 | ||
| Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells. | Q39771508 | ||
| Acetylated NPM1 localizes in the nucleoplasm and regulates transcriptional activation of genes implicated in oral cancer manifestation | Q39828468 | ||
| Nucleophosmin/B23 interacts with p21WAF1/CIP1 and contributes to its stability | Q39883157 | ||
| SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin | Q39959494 | ||
| Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription | Q39997668 | ||
| Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell | Q40044845 | ||
| Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells. | Q40143098 | ||
| Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. | Q40321232 | ||
| Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells | Q40407663 | ||
| Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. | Q40525549 | ||
| Stability of nucleolar versus non-nucleolar forms of human p14(ARF). | Q40529860 | ||
| Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. | Q40613625 | ||
| Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing | Q40666241 | ||
| Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function | Q41036948 | ||
| Assisted protein folding | Q41397424 | ||
| Identification of Ag-NOR Proteins, Markers of Proliferation Related to Ribosomal Gene Activity | Q41441034 | ||
| Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription | Q41813111 | ||
| Evidence for the ability of nucleophosmin/B23 to bind ATP | Q42032009 | ||
| Nucleophosmin/B23 regulates ubiquitin dynamics in nucleoli by recruiting deubiquitylating enzyme USP36. | Q42126825 | ||
| Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant | Q42804288 | ||
| A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF. | Q42806442 | ||
| Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein | Q42809562 | ||
| Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation | Q24293167 | ||
| Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase | Q24295278 | ||
| Nucleophosmin acts as a novel AP2alpha-binding transcriptional corepressor during cell differentiation | Q24298255 | ||
| The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype | Q24299527 | ||
| Nucleophosmin regulates the stability and transcriptional activity of p53 | Q24300176 | ||
| Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3 | Q24301019 | ||
| Polo-like kinase 2-dependent phosphorylation of NPM/B23 on serine 4 triggers centriole duplication | Q24305141 | ||
| Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication | Q24309486 | ||
| Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR | Q24311493 | ||
| The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing | Q24312057 | ||
| Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome | Q24315004 | ||
| Centromere-specific assembly of CENP-a nucleosomes is mediated by HJURP. | Q24321321 | ||
| Nucleophosmin is essential for ribosomal protein L5 nuclear export | Q24322766 | ||
| PARP-1 and PARP-2 interact with nucleophosmin/B23 and accumulate in transcriptionally active nucleoli | Q24329068 | ||
| Identification of nucleophosmin as an NF-kappaB co-activator for the induction of the human SOD2 gene | Q24337067 | ||
| Phosphoproteome analysis of the human mitotic spindle | Q24547339 | ||
| N-terminal polyubiquitination and degradation of the Arf tumor suppressor | Q24561681 | ||
| p53-independent functions of the p19(ARF) tumor suppressor | Q24600863 | ||
| Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23 | Q24629309 | ||
| Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation | Q24642177 | ||
| Nuclear Akt interacts with B23/NPM and protects it from proteolytic cleavage, enhancing cell survival | Q24650827 | ||
| Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin | Q24652323 | ||
| Nucleolar protein B23/nucleophosmin regulates the vertebrate SUMO pathway through SENP3 and SENP5 proteases | Q24657753 | ||
| DNMT3A Mutations in Acute Myeloid Leukemia | Q27559610 | ||
| In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 | Q27642888 | ||
| Structural Consequences of Nucleophosmin Mutations in Acute Myeloid Leukemia | Q27650716 | ||
| Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype | Q27824827 | ||
| Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations | Q27824843 | ||
| Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype | Q27824844 | ||
| Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). | Q27824861 | ||
| Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia | Q27851430 | ||
| Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B. | Q27851460 | ||
| Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML. | Q27851476 | ||
| The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: ... | Q27856359 | ||
| Tumor suppression by Ink4a-Arf: progress and puzzles | Q28207959 | ||
| The human CENP-A centromeric nucleosome-associated complex | Q28235264 | ||
| CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species | Q28242132 | ||
| Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma | Q28250347 | ||
| The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly | Q28271991 | ||
| MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia | Q28272533 | ||
| A B-cell-specific DNA Recombination Complex | Q28274822 | ||
| Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias | Q28301353 | ||
| ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway | Q28506702 | ||
| Defining the molecular basis of Arf and Hdm2 interactions | Q28507075 | ||
| Nucleophosmin/B23, a nuclear PI(3,4,5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD | Q28567152 | ||
| Preferential cleavage in pre-ribosomal RNA byprotein B23 endoribonuclease | Q28568636 | ||
| Nucleolar protein B23.1 binds to retinoblastoma protein and synergistically stimulates DNA polymerase alpha activity | Q28571658 | ||
| Protein B23/nucleophosmin/numatrin nuclear dynamics in relation to protein kinase CK2 and apoptotic activity in prostate cells | Q28574087 | ||
| Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma | Q28589317 | ||
| Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing | Q28590167 | ||
| Role of nucleophosmin in embryonic development and tumorigenesis | Q28591282 | ||
| Nucleophosmin is required for DNA integrity and p19Arf protein stability | Q28593126 | ||
| A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth | Q28910214 | ||
| CRM1 is responsible for intracellular transport mediated by the nuclear export signal | Q29547861 | ||
| Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization | Q29614701 | ||
| Post-translational modifications and activation of p53 by genotoxic stresses | Q29615659 | ||
| Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints | Q29617405 | ||
| Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication | Q29617915 | ||
| Restoration of p53 function leads to tumour regression in vivo | Q29618727 | ||
| Nucleolar Arf sequesters Mdm2 and activates p53 | Q29620244 | ||
| Major nucleolar proteins shuttle between nucleus and cytoplasm | Q29620425 | ||
| Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification | Q33254865 | ||
| Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. | Q33261981 | ||
| Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations | Q33327492 | ||
| Nucleophosmin is selectively deposited on mRNA during polyadenylation | Q33611294 | ||
| NPM phosphorylation stimulates Cdk1, overrides G2/M checkpoint and increases leukemic blasts in mice | Q33615300 | ||
| Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction | Q33722630 | ||
| Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability | Q33773430 | ||
| The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model | Q33806066 | ||
| Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish. | Q33806096 | ||
| Sumoylation induced by the Arf tumor suppressor: a p53-independent function | Q33821331 | ||
| Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. | Q33940550 | ||
| The ribonuclease activity of nucleolar protein B23. | Q34775233 | ||
| Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3. | Q34864658 | ||
| Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36. | Q34942101 | ||
| Nuclear transport as a target for cell growth | Q35058962 | ||
| INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. | Q35208402 | ||
| Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival | Q35834460 | ||
| Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction | Q35848938 | ||
| The incidence and clinical significance of nucleophosmin mutations in childhood AML. | Q35901721 | ||
| Pathobiology of ALK+ anaplastic large-cell lymphoma | Q36007756 | ||
| Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse | Q36508976 | ||
| Nucleophosmin: a versatile molecule associated with hematological malignancies. | Q36597677 | ||
| New insights into the nucleophosmin/nucleoplasmin family of nuclear chaperones | Q36691603 | ||
| Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances | Q36719212 | ||
| Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation | Q36842905 | ||
| Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma | Q36851904 | ||
| TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice | Q36868764 | ||
| Posttranscriptional regulation of chicken ccn2 gene expression by nucleophosmin/B23 during chondrocyte differentiation | Q36898985 | ||
| Histone chaperones: 30 years from isolation to elucidation of the mechanisms of nucleosome assembly and disassembly | Q36978890 | ||
| Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation | Q36999887 | ||
| Identification of nuclear export inhibitors with potent anticancer activity in vivo | Q37081966 | ||
| Nucleophosmin blocks mitochondrial localization of p53 and apoptosis | Q37269134 | ||
| Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression | Q42820510 | ||
| Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants | Q42826742 | ||
| Recruitment of phosphorylated NPM1 to sites of DNA damage through RNF8-dependent ubiquitin conjugates | Q42936127 | ||
| Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability | Q43188148 | ||
| Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. | Q43594592 | ||
| Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells | Q43757315 | ||
| NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. | Q44211040 | ||
| NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features | Q44257677 | ||
| A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells | Q44714283 | ||
| B23/nucleophosmin serine 4 phosphorylation mediates mitotic functions of polo-like kinase 1. | Q44931323 | ||
| Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells. | Q45083325 | ||
| Successful all-trans retinoic acid treatment of acute promyelocytic leukemia in a patient with NPM/RAR fusion | Q46910183 | ||
| Nucleophosmin is required for chromosome congression, proper mitotic spindle formation, and kinetochore-microtubule attachment in HeLa cells | Q47275104 | ||
| AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features | Q47834838 | ||
| Identification of nucleophosmin/B23, an acidic nucleolar protein, as a stimulatory factor for in vitro replication of adenovirus DNA complexed with viral basic core proteins. | Q48352383 | ||
| Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin | Q50335728 | ||
| Nucleophosmin regulates cell cycle progression and stress response in hematopoietic stem/progenitor cells | Q50941059 | ||
| RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells | Q51926763 | ||
| B23 acts as a nucleolar stress sensor and promotes cell survival through its dynamic interaction with hnRNPU and hnRNPA1. | Q52598299 | ||
| The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence. | Q53332784 | ||
| Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis | Q53520827 | ||
| C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders | Q53622524 | ||
| Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal | Q53778913 | ||
| Increased expression of a COOH-truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells. | Q53960148 | ||
| NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. | Q54546998 | ||
| Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements. | Q54627394 | ||
| The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia. | Q54693168 | ||
| Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase | Q57985211 | ||
| Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia | Q58882378 | ||
| Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance | Q58882381 | ||
| CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice | Q60171380 | ||
| Modification of Nucleolar Protein B23 after Exposure to Ionizing Radiation | Q71947164 | ||
| Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis | Q73131404 | ||
| Mapping the functional domains of nucleolar protein B23 | Q73829236 | ||
| Involvement of nucleophosmin/B23 in the response of HeLa cells to UV irradiation | Q77441044 | ||
| Role of protein kinase CK2 phosphorylation in the molecular chaperone activity of nucleolar protein b23 | Q78744755 | ||
| Identification and functional characterization of a cytoplasmic nucleophosmin leukaemic mutant generated by a novel exon-11 NPM1 mutation | Q79777403 | ||
| Effects of interphase and mitotic phosphorylation on the mobility and location of nucleolar protein B23 | Q80121350 | ||
| Nek2A kinase regulates the localization of numatrin to centrosome in mitosis | Q80606618 | ||
| B23 regulates GADD45a nuclear translocation and contributes to GADD45a-induced cell cycle G2-M arrest | Q81255797 | ||
| Therapy-related acute myeloid leukaemia with mutated NPM1: treatment induced or de novo in origin? | Q81270867 | ||
| Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype | Q81712971 | ||
| Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia | Q81919725 | ||
| NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype | Q83296699 | ||
| A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias | Q84386374 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | complex network | Q665189 |
| P304 | page(s) | 2595-2609 | |
| P577 | publication date | 2011-01-31 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases | |
| P478 | volume | 30 |
| Q36961022 | 14-3-3γ Prevents Centrosome Amplification and Neoplastic Progression |
| Q28543087 | A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts |
| Q24297713 | A novel proapoptotic gene PANO encodes a post-translational modulator of the tumor suppressor p14ARF |
| Q34545871 | A redox mechanism underlying nucleolar stress sensing by nucleophosmin |
| Q34227622 | AKT regulates NPM dependent ARF localization and p53mut stability in tumors |
| Q42580457 | AML cells carrying NPM1 mutation are resistant to nucleophosmin displacement from nucleoli caused by the G-quadruplex ligand TmPyP4. |
| Q91895710 | APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC |
| Q36328692 | Aberrant expression of ALK and EZH2 in Merkel cell carcinoma |
| Q38535094 | Autoregulatory circuit of human rpL3 expression requires hnRNP H1, NPM and KHSRP |
| Q47242292 | B23/nucleophosmin interacts with bovine immunodeficiency virus Rev protein and facilitates viral replication |
| Q38242945 | Berberine, an epiphany against cancer. |
| Q35857057 | Biophysical Characterization of Nucleophosmin Interactions with Human Immunodeficiency Virus Rev and Herpes Simplex Virus US11. |
| Q42635149 | Conformational stabilization as a strategy to prevent nucleophosmin mislocalization in leukemia |
| Q38961549 | Curcumin homing to the nucleolus: mechanism for initiation of an apoptotic program |
| Q37932085 | Current findings for recurring mutations in acute myeloid leukemia |
| Q92144514 | DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia |
| Q42321110 | Destabilisation, aggregation, toxicity and cytosolic mislocalisation of nucleophosmin regions associated with acute myeloid leukemia. |
| Q39062444 | Different functions of HOPS isoforms in the cell: HOPS shuttling isoform is determined by RIP cleavage system |
| Q42290643 | Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin |
| Q35504874 | Dynamic conformations of nucleophosmin (NPM1) at a key monomer-monomer interface affect oligomer stability and interactions with granzyme B. |
| Q34645436 | Dysregulation of RNA polymerase I transcription during disease. |
| Q64078574 | Emerging Role of the Nucleolar Stress Response in Autophagy |
| Q27026649 | Emerging roles of the nucleolus in regulating the DNA damage response: the noncanonical DNA repair enzyme APE1/Ref-1 as a paradigmatical example |
| Q36116345 | Expression of Nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells |
| Q42546269 | Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADD. |
| Q37141959 | Far upstream element binding protein 1: a commander of transcription, translation and beyond |
| Q39126232 | Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer |
| Q39129437 | Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology. |
| Q30032659 | GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer |
| Q39298018 | Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network. |
| Q35343013 | Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma |
| Q33877215 | Identification of Microprotein-Protein Interactions via APEX Tagging |
| Q47239822 | Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf. |
| Q37553863 | Identification of chaperones in a MPP+-induced and ATRA/TPA-differentiated SH-SY5Y cell PD model |
| Q35981110 | Identification of protein targets of reactive metabolites of tienilic acid in human hepatocytes |
| Q35072625 | Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer |
| Q64259145 | Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging |
| Q35599868 | Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties |
| Q39181954 | Interactomic approach for evaluating nucleophosmin‐binding proteins as biomarkers for Ewing's sarcoma |
| Q34683193 | Loss of nucleolar histone chaperone NPM1 triggers rearrangement of heterochromatin and synergizes with a deficiency in DNA methyltransferase DNMT3A to drive ribosomal DNA transcription |
| Q26750653 | Molecules that target nucleophosmin for cancer treatment: an update |
| Q34086334 | Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse |
| Q89777322 | Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia |
| Q39997449 | Myeloid leukemia factor: a return ticket from human leukemia to fly hematopoiesis |
| Q42254184 | NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases. |
| Q83117850 | NPM-MLF1 synergizes with Npm haploinsufficiency to enhance myeloid progenitor activity |
| Q38820099 | NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape. |
| Q39113519 | NPM–RAR, not the RAR–NPM reciprocal t(5;17)(q35;q21) acute promyelocytic leukemia fusion protein, inhibits myeloid differentiation |
| Q37931279 | Nuclear phosphoinositides and their roles in cell biology and disease |
| Q92932241 | Nucleolar Stress: hallmarks, sensing mechanism and diseases |
| Q36781105 | Nucleolar repression facilitates initiation and maintenance of senescence |
| Q34183329 | Nucleolar stress with and without p53. |
| Q34047444 | Nucleolin and nucleophosmin: nucleolar proteins with multiple functions in DNA repair |
| Q50074509 | Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis. |
| Q38824781 | Nucleolus-derived mediators in oncogenic stress response and activation of p53-dependent pathways |
| Q56058269 | Nucleolus: Structure and Function |
| Q24316988 | Nucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells |
| Q39174595 | Nucleophosmin 1, upregulated in adenomas and cancers of the colon, inhibits p53‐mediated cellular senescence |
| Q36534039 | Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling |
| Q38780814 | Nucleophosmin Regulates Intracellular Oxidative Stress Homeostasis via Antioxidant PRDX6. |
| Q41908850 | Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein |
| Q36673676 | Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA. |
| Q42254875 | Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription |
| Q30577959 | Nucleophosmin modulates stability, activity, and nucleolar accumulation of base excision repair proteins. |
| Q34035133 | Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA |
| Q38084251 | Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization. |
| Q89768685 | Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia |
| Q47397272 | Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells |
| Q59134798 | Phosphoproteome Profiling Reveals Multifunctional Protein NPM1 as part of the Irradiation Response of Tumor Cells |
| Q28554321 | Phosphorylation of Def Regulates Nucleolar p53 Turnover and Cell Cycle Progression through Def Recruitment of Calpain3 |
| Q38977653 | Physical and functional interaction of the TPL2 kinase with nucleophosmin |
| Q44197854 | Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation. |
| Q100736995 | Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia |
| Q34648744 | Proteasome activity influences UV-mediated subnuclear localization changes of NPM. |
| Q39365630 | Proteomic Profiling of EBNA1-Host Protein Interactions in Latent and Lytic Epstein-Barr Virus Infections |
| Q39407617 | Proteomic analysis of UVB-induced protein expression- and redox-dependent changes in skin fibroblasts using lysine- and cysteine-labeling two-dimensional difference gel electrophoresis |
| Q38496343 | Quantitative proteomic analysis and functional studies reveal that nucleophosmin is involved in cell death in glioblastoma cell line transfected with siRNA. |
| Q92720720 | RNA-Binding Protein HuR Regulates Rac1 Nucleocytoplasmic Shuttling Through Nucleophosmin in the Intestinal Epithelium |
| Q48297862 | Reconstitution of the oocyte nucleolus in mice through a single nucleolar protein, NPM2. |
| Q37115966 | Regulation of host gene expression by HIV-1 TAR microRNAs. |
| Q42710172 | Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib |
| Q39317353 | S-Nitrosylation Regulates Cell Survival and Death in the Central Nervous System |
| Q38836332 | Scaffold Diversity Synthesis and Its Application in Probe and Drug Discovery. |
| Q33739307 | Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients |
| Q37678494 | Stressing on the nucleolus in cardiovascular disease |
| Q41842682 | Structural investigation of nucleophosmin interaction with the tumor suppressor Fbw7γ. |
| Q27682111 | Structural polymorphism in the N-terminal oligomerization domain of NPM1 |
| Q28114773 | Subcellular fractionation and localization studies reveal a direct interaction of the fragile X mental retardation protein (FMRP) with nucleolin |
| Q30585577 | Synergic role of nucleophosmin three-helix bundle and a flanking unstructured tail in the interaction with G-quadruplex DNA. |
| Q42244254 | TPL2-NPM-p53 pathway monitors nucleolar stress |
| Q37484539 | The Cell’s Nucleolus: an Emerging Target for Chemotherapeutic Intervention |
| Q45094905 | The Spatial Organization of the Intranuclear Structures of Human Brain Dopaminergic Neurons |
| Q39944723 | The Wnt Target Protein Peter Pan Defines a Novel p53-independent Nucleolar Stress-Response Pathway |
| Q35844124 | The expression of B23 and EGR1 proteins is functionally linked in tumor cells under stress conditions. |
| Q35562110 | The interaction of mycobacterial protein Rv2966c with host chromatin is mediated through non-CpG methylation and histone H3/H4 binding |
| Q41091731 | The leukemic oncoprotein NPM1-RARA inhibits TP53 activity |
| Q41905674 | The nucleolar protein nucleophosmin is essential for autophagy induced by inhibiting Pol I transcription |
| Q27010254 | The role of MIZ-1 in MYC-dependent tumorigenesis |
| Q54977441 | Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why. |
| Q42979880 | Use of sorafenib for post-transplant relapse in FLT3/ITD-positive acute myelogenous leukemia: maturation induction and cytotoxic effect |
Search more.